PROMIS NEUROSCIENCES
ProMIS Neurosciences is a development-stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular, Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS). It was founded in 2004 and headquartered in Toronto, Canada.
PROMIS NEUROSCIENCES
Industry:
Biotechnology Health Diagnostics Medical Neuroscience Therapeutics
Founded:
2004-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.promisneurosciences.com
Total Employee:
1+
Status:
Active
Contact:
(416) 847-6898
Email Addresses:
[email protected]
Total Funding:
162.17 M USD
Technology used in webpage:
Euro Google Adsense Amazon Ireland Region
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Dimension Therapeutics
Dimension Therapeutics is a gene therapy company developing novel treatments for rare diseases.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Visterra
Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Armistice Capital
Armistice Capital investment in Post-IPO Equity - ProMIS Neurosciences
Great Point Partners
Great Point Partners investment in Post-IPO Equity - ProMIS Neurosciences
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Post-IPO Equity - ProMIS Neurosciences
Ally Bridge Group
Ally Bridge Group investment in Post-IPO Equity - ProMIS Neurosciences
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Post-IPO Equity - ProMIS Neurosciences
Affinity Asset Advisors
Affinity Asset Advisors investment in Post-IPO Equity - ProMIS Neurosciences
Ally Bridge Group
Ally Bridge Group investment in Post-IPO Equity - ProMIS Neurosciences
Key Employee Changes
Official Site Inspections
http://www.promisneurosciences.com Semrush global rank: 6.31 M Semrush visits lastest month: 1.05 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "ProMIS Neurosciences"
ProMISâ„¢ Neurosciences, Inc. - LinkedIn
ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with the …See details»
ProMIS Neurosciences - Crunchbase Company Profile …
ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.See details»
ProMIS Neurosciences (PMN) Company Profile & Description
Jul 21, 2025 Company profile for ProMIS Neurosciences, Inc. (PMN) stock, with a description, list of executives, contact details and other key facts.See details»
ProMIS Neurosciences 2025 Company Profile: Stock ... - PitchBook
Information on stock, financials, earnings, subsidiaries, investors, and executives for ProMIS Neurosciences. Use the PitchBook Platform to explore the full profile.See details»
ProMIS Neurosciences Company Profile | Management and
Find contact information for ProMIS Neurosciences. Learn about their Research & Development, Business Services market share, competitors, and ProMIS Neurosciences's email format.See details»
ProMIS Neurosciences - Craft
Jul 21, 2023 ProMIS Neurosciences is a biotechnology company focused on discovering and developing antibody therapeutics selectively targeting toxic oligomers implicated in the …See details»
ProMIS Neurosciences, Inc. - CEO and Investor Conference 2025
Feb 10, 2025 ProMIS Neurosciences Inc. is a clinical stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins …See details»
ProMIS Neurosciences - lifesciencehistory.com
ProMIS Neurosciences is a development stage biotechnology company focused on discovering and developing therapeutics selectively targeting toxic misfolded oligomers implicated in the …See details»
ProMIS Neurosciences, Inc. (PMN)
Jul 22, 2025 Innovative Protein Folding Predictions A Revolutionary Breakthrough in Precision Medicine Based on the leading science of Dr. Neil Cashman, our proprietary target discovery engine, EpiSelectâ„¢, utilizes …See details»
ProMISâ„¢ Neurosciences, Inc. - LinkedIn
ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with the development ...See details»
ProMIS Neurosciences, Inc. - Executive Bio, Top Executies, and ...
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada.See details»
ProMIS Neurosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Jul 22, 2025 Explore ProMIS Neurosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 105 news, and 2 literature, Disease Domain ...See details»
ProMIS Neurosciences Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ProMIS Neurosciences Inc of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
ProMIS Neurosciences Announces $20.4 Million Private
Aug 21, 2023 ProMIS Neurosciences Announces $20.4 Million Private Placement Financing August 21, 2023 16:12 ET | Source: ProMIS Neurosciences Inc.See details»
Management Team :: ProMIS Neurosciences, Inc. (PMN)
Mr. Warma currently serves on the Board of Directors of the Biotechnology Innovation Organization (BIO). Mr. Warma obtained an honors Bachelor of Science degree specializing in …See details»
ProMIS Neurosciences Announces Private Placement Financing
1 day ago ProMIS Neurosciences Announces Private Placement Financing $3 million private financing plus an additional $9 million of proceeds due to exercise of warrants, for gross …See details»
Investors :: ProMIS Neurosciences, Inc. (PMN)
Jun 17, 2025 Company Overview ProMISâ„¢ Neurosciences, Inc. (Nasdaq: PMN), is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics …See details»
ProMIS Neurosciences to Showcase Protein-Misfolding Drug …
2 hours ago Presentation to highlight the Company’s proprietary protein-misfolding platform, EpiSelectTM, used to develop PMN310 Posters highlighting PRECISE-AD, the Company’s …See details»
Press Releases :: ProMIS Neurosciences, Inc. (PMN)
Jun 17, 2025 ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease …See details»
ProMIS Neurosciences Announces Private Placement Financing
1 day ago $3 million private financing plus an additional $9 million of proceeds due to exercise of warrants, for gross proceeds of approximately $12.0 million TORONTO, Ontario and …See details»